BOSTON, March 25 (Reuters) – U.S. legislators investigating price hikes in the pharmaceutical industry have asked William Ackman’s hedge fund for information on Valeant Pharmaceuticals International…
The post Senate’s request for info from Ackman related to Valeant-source appeared first on NASDAQ.